Gefitinib: all 239 studies that test it
Page 2 of 3. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung CancerCompletedNCT01196234Phase 2
- Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsStatus unknownNCT01192243Phase 2
- A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell CarcinomaCompletedNCT01185158Phase 2
- Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyStatus unknownNCT01066195Phase 3
- A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
- UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung CancerCompletedNCT01037998Phase 2
- Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT01024712Phase 2
- Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mgCompletedNCT01017679Phase 2
- Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)SuspendedNCT00986284Phase 2
- Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00955695Phase 3
- Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT00891579Phase 2
- Hydroxychloroquine and Gefitinib to Treat Lung CancerStatus unknownNCT00809237Phase 1/2
- Randomized Gefitinib TrialCompletedNCT00807066Phase 3
- An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant MesotheliomaCompletedNCT00787410Phase 2
- Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck CancerCompletedNCT00681967Phase 1
- Ph II Early BC Pre-Surgical Biologic StudyCompletedNCT00637026Phase 2
- Open-Label Extension of Other SZ1839 (Iressa) TrialsCompletedNCT00635973Phase 3
- Open Label Trial to Assess Iressa in Prostate Cancer PatientsCompletedNCT00635856Phase 2
- IRESSA™ (Gefitinib) in Breast Cancer PatientsCompletedNCT00632723Phase 2
- Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung CancerStatus unknownNCT00616499Phase 2
- Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung CancerStatus unknownNCT00614809Phase 2
- Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced CancerCompletedNCT00502060Phase 1
- Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based ChemotherapyStatus unknownNCT00497250Phase 1
- Iressa as Second Line Therapy in Advanced NSCLC-AsiaCompletedNCT00478049Phase 3
- First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never SmokerCompletedNCT00455936Phase 3
- A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast CancerCompletedNCT00428896Phase 2
- Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin CancerStatus unknownNCT00423397Phase 1/2
- Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00411047Phase 2
- High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR MutationsCompletedNCT00372515Phase 1
- BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerTerminatedNCT00352079Phase 3
- Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCStatus unknownNCT00319800Phase 2
- Combination Casodex® and Iressa™ in Locally Advanced Prostate CancerCompletedNCT00319787Phase 2
- Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
- A Study of IRESSA in Relapsed and Refractory Small Cell Lung CancerCompletedNCT00298688Phase 2
- Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryTerminatedNCT00290719Phase 1
- Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular CarcinomaStatus unknownNCT00282100Phase 2
- Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung CancerWithdrawnNCT00268255Phase 1/2
- Trial of Iressa in Prostate Cancer PatientsCompletedNCT00265070Phase 2
- Iressa v BSC (Best Supportive Care) in First Line NSCLCCompletedNCT00259064Phase 2/3
- Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction CancerCompletedNCT00258323Phase 2
- Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By SurgeryTerminatedNCT00258297Phase 2
- A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung CancerCompletedNCT00255489Phase 1
- A Study of ZD1839 Effects on Cell Proliferation in Breast CancerWithdrawnNCT00252811Phase 2
- Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCTCompletedNCT00246974Phase 2
- Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerCompletedNCT00242918Phase 2
- Iressa vs Best Supportive Care - 2nd/3rd Line Survival StudyCompletedNCT00242801Phase 3
- IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo FailureCompletedNCT00242788Phase 1/2
- ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCompletedNCT00242762Phase 2
- IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck CarcinomaCompletedNCT00242749Phase 2
- Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or RadiotherapyCompletedNCT00241475Phase 2
- Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast CancerCompletedNCT00239343Phase 2
- Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerCompletedNCT00239304Phase 1/2
- Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate CancerCompletedNCT00239291Phase 1/2
- A Phase II Exploratory, Multicentre, Open-label, Non-comparative Study of ZD1839 (Iressa) and Radiotherapy in the Treatment of Patients With Glioblastoma MultiformeCompletedNCT00238797Phase 2
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerCompletedNCT00238628Phase 1/2
- Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesCompletedNCT00238251Phase 2
- Gefitinib in Combination With Chemoradiation in Resectable Gastric CancerTerminatedNCT00237900Phase 1/2
- Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLCTerminatedNCT00234468Phase 3
- Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerTerminatedNCT00234442Phase 2
- A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal CarcinomaCompletedNCT00234429Phase 2/3
- A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast CancerCompletedNCT00234403Phase 2
- Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT00233636Phase 2
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyCompletedNCT00229697Phase 2
- Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck CarcinomaCompletedNCT00228488Phase 2
- Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00217698Phase 2
- Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasCompletedNCT00215995Phase 2
- Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)CompletedNCT00215202Phase 2
- A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2
- Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer PatientsTerminatedNCT00206492Phase 2
- Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast CancerTerminatedNCT00206414Phase 2
- Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
- Treatment of Lung Adenocarcinoma With Bronchioloalveolar FeatureCompletedNCT00198380Phase 2
- A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFRTerminatedNCT00198159Phase 2
- Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck CancerTerminatedNCT00195078Phase 1/2
- Iressa in Poor Performance Status Patients With Previously Untreated Advanced Non-Small Cell Lung CancerCompletedNCT00193336Phase 2
- Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck CancerCompletedNCT00193284Phase 2
- A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based TherapyCompletedNCT00189358Phase 2
- Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLCCompletedNCT00188617Phase 2
- Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and NeckCompletedNCT00185835Phase 1
- Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian CancerCompletedNCT00181688Phase 2
- Study of Gefitinib and Docetaxel as Salvage Therapy in Advanced Pancreatic CarcinomaCompletedNCT00177242Phase 2
- Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung CancerCompletedNCT00173875Phase 2
- Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract CarcinomasTerminatedNCT00169221Phase 2
- A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNCT00162318Phase 1
- Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic CancerCompletedNCT00137761Phase 2
- Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous LeukemiaCompletedNCT00130702Phase 2
- Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or MetastaticCompletedNCT00127829Phase 1
- Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung CancerCompletedNCT00103051Phase 2
- Gefitinib in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00100945Phase 2
- Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00098462Phase 1/2
- Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal CancerTerminatedNCT00093652Phase 1/2
- Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNCT00091156Phase 3
- Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung CancerWithdrawnNCT00090675Phase 3
- Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00087334Phase 1/2
- Gefitinib and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00084786Phase 1
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid TumorsCompletedNCT00084708Phase 1
- Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckCompletedNCT00083057Phase 1
- Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the BreastTerminatedNCT00082667Phase 2
- Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00080340Phase 3